Bellone S, Roque DM, Siegel ER, Buza N, et al. A phase II evaluation of pembrolizumab in recurrent microsatellite
instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1
methylated characteristics (NCT02899793). Ann Oncol 2021 Apr 28. pii: S0923-7534(21)01170.
PMID: 33932502